glp-1 9 in 1 Glucagon-like peptide-1 cleavage product GLP-1(9–36) reduces neuroinflammation from stroke via the activation of insulin-like growth factor receptor astrocytes GLP-ONE + Receptor Activator |

Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: A meta-analysis of clinical trials

Dev Med Child Neurol 2005

Similarly, patients with obesity and metabolic syndrome often exhibit chronic low-grade inflammation, and GLP-1 receptor agonists approved for weight management may address both adiposity and inflammatory burden simultaneously

A small observational study published in JCI Insight (2022) examined individuals with obesity receiving semaglutide who reported reductions in alcohol intake, though the relationship to weight loss requires further investigation in controlled trials